Woburn, MA, United States of America

Sylvie Bernier

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Praecis Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sylvie Bernier. Retrieved from https://idiyas.com/inventor/sylvie-bernier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sylvie Bernier: Innovator in Immunosuppressive Agents

Introduction

Sylvie Bernier is a notable inventor based in Woburn, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of immunosuppressive agents.

Latest Patents

Sylvie holds a patent for Sphingosine-1-phosphate (SIP) receptor agonists. This invention provides compounds formula I, their preparation, and their use as pharmaceutically active immunosuppressive agents for the treatment of autoimmune disorders, organ transplant rejection, and disorders associated with an activated immune system. Additionally, her work addresses other disorders modulated by lymphopenia or S1P receptors. She has 1 patent to her name.

Career Highlights

Sylvie is currently associated with Praecis Pharmaceuticals, Inc., where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in advancing treatments that improve patient outcomes in various medical conditions.

Collaborations

Throughout her career, Sylvie has collaborated with notable colleagues, including Aaron Coffin and Hongfang Yang. These partnerships have enhanced her research and development efforts.

Conclusion

Sylvie Bernier's contributions to immunosuppressive agents highlight her role as a leading inventor in the pharmaceutical industry. Her innovative work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…